COMMUNIQUÉS West-GlobeNewswire

Sensorion Enters Into Exclusive Negotiations with Pasteur Institute for Hearing Loss Gene Therapy Programs
23/11/2018
MONTPELLIER, France, Nov. 23, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN / PEA-PME eligible) announced today that it has entered into a letter of intent with Pasteur Institute (Paris, France) to [...]
Nova Leap Health Corp. Reports Third Quarter 2018 Financial Results and Provides Corporate Update
23/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Nov. 22, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
North Bud Farms Provides Corporate Update
22/11/2018
TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) ("NORTHBUD" or the "Company") is pleased to provide shareholders with an update on our corporate activities. Construction of our Cannabis [...]
Agility Health Announces Demand by Lender and Notice of Intention to Enforce Security
22/11/2018
HAMILTON, Ontario, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“Agility Health” or “Corporation”), a provider of orthotics, prosthetics and foot care services in Canada, today reported that its [...]
Canadian company proves exercise is a miracle drug
22/11/2018
Gym members see significant reductions in blood pressure, weight within 6 months of joining powerful exercise and healthy lifestyle coaching program VANCOUVER, British Columbia, Nov. 22, 2018 (GLOBE NEWSWIRE) -- For the [...]
Oral semaglutide demonstrates greater reductions in both HbA1c and body weight compared to Victoza® in Japanese people with type 2 diabetes
22/11/2018
Bagsværd, Denmark, 22 November 2018 - Novo Nordisk today announced the headline results from PIONEER 9, a 52-week trial with oral semaglutide vs Victoza ® (0.9 mg liraglutide) and vs placebo, all as monotherapy, in [...]
Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse
22/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (“ Canopy Rivers ” or the “ Company ”) (TSXV: RIV) is pleased to announce it has, [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2018
22/11/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Nov. 22, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces [...]
Canada House Grants Common Shares to Senior Executive Management
22/11/2018
TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) is pleased to announce the immediate granting of 4,300,000 stock options to senior employees at an [...]
Emerald Health Therapeutics Appoints Agro-Biotech President
22/11/2018
Thierry Schmidt brings extensive marketing and business strategy experience from consumer goods industry VICTORIA, British Columbia, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: [...]
Emerald Health Therapeutics nomme le président d’Agro-Biotech
22/11/2018
Thierry Schmidt apporte une vaste expérience en marketing et en stratégie commerciale provenant du secteur des biens de consommation VICTORIA, Colombie-Britannique, 22 nov. 2018 (GLOBE NEWSWIRE) -- Emerald Health [...]
Tetra Bio-Pharma Seeks Solutions for Second Hand Smoke From Cannabis
22/11/2018
ORLEANS, Ontario, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to update the market on its [...]
The Management Board of JSC Olainfarm: shareholders chose stability and development by their voting
22/11/2018
Commenting on the decisions adopted by today's Extraordinary Shareholders' General Meeting of JSC Olainfarm, the Management Board of the company appreciates the voting of shareholders to leave the existing Articles of [...]
Oasmia Pharmaceutical Receives Approval from European Commission for Apealea® (paclitaxel micellar) in the European Union
22/11/2018
Apealea is approved in the European Union for treatment of platinum-sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer in combination with carboplatin in first relapse Uppsala, [...]
Resolutions of the Extraordinary General Meeting of shareholders of JSC Olainfarm, held on November 22, 2018
22/11/2018
The extraordinary general meeting of shareholders of JSC Olainfarm, held today, on November 22 in JSC Olainfarm premises - Olaine, Rūpnīcu street 5, resolved decisions initiated and proposed by the shareholders Anna [...]
Rule 2.9 Announcement
22/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 22 November 2018 [...]
FIT Biotech Oy: FIT Biotech expands R&D pipeline
22/11/2018
FIT Biotech Oy Company release 22.11.2018 at 08:30 AM EET FIT Biotech expands R&D pipeline FIT Biotech Oy ("FIT Biotech", "Company", FITBIO: FN Finland) announced that it has included two new candidates to its R [...]
Addex Van Leeuwenhoeck Equity Research Report Highlights Deep Pipeline Well Funded through Pivotal Registration Study and Increases Price Target to CHF 14
22/11/2018
Geneva, Switzerland, 22 November 2018 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that the independent life science equity [...]
SeaSpine to Participate in the 30th Annual Piper Jaffray Healthcare Conference
21/11/2018
CARLSBAD, Calif., Nov. 21, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Pages